Soterix Medical

Soterix Medical is a US-based medical device company specializing in non-invasive neuromodulation technology, primarily transcranial direct current stimulation (tDCS); the company develops tDCS devices used in clinical research trials for treatment-resistant depression, bipolar depression, and substance use disorders, and has contributed to ketamine biomarker validation research exploring how neuromodulation biomarkers can predict or complement ketamine treatment response in patients with major depressive disorder.